Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

April 18, 2021
Review

Mechanistic Insights from REDUCE-IT STRENGTHen the Case Against Triglyceride Lowering as a Strategy for Cardiovascular Disease Risk Reduction.

The American Journal of Medicine
R Preston Mason, Robert H Eckel
April 18, 2021

Aspirin facilitates trophoblast invasion and epithelial-mesenchymal transition by regulating the miR-200-ZEB1 axis in preeclampsia.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Mei-Tsz SuPao-Lin Kuo
April 18, 2021

Intraoperative methylprednisolone and neurodevelopmental outcomes in infants after cardiac surgery.

The Annals of Thoracic Surgery
Sinai C ZyblewskiEric M Graham
April 18, 2021

DNA Hypomethylation of the MPO Gene in Peripheral Blood Leukocytes Is Associated with Cerebral Stroke in the Acute Phase.

Journal of Molecular Neuroscience : MN
Olga BushuevaMaria Nazarenko
April 18, 2021

Pulse arrival time, a novel sleep cardiovascular marker: the multi-ethnic study of atherosclerosis.

Thorax
Younghoon KwonAli Azarbarzin
April 18, 2021

The Latest Advances in Imaging Crosstalk Between the Immune System and Fibrosis in Cardiovascular Disease.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Gyu Seong HeoYongjian Liu
April 16, 2021

Proteome characterisation of extracellular vesicles isolated from heart.

Proteomics
Bethany ClaridgeDavid W Greening
April 16, 2021

Impact of cardiovascular disease and cardiovascular risk factors in hospitalised COVID-19 patients.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
L S D JewbaliH J Siebelink
April 16, 2021
Review

The link among microbiota, epigenetics, and disease development.

Environmental Science and Pollution Research International
Amr El-SayedMohamed Kamel
April 16, 2021
Open Access

Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistance.

Scientific Reports
Katharina LechnerHelene von Bibra
April 16, 2021

No correlation between mean platelet volume and carotid artery thickness in patients with diabetes at intermediate or high risk for cardiovascular diseases.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
Keita SadataniNobuo Sezaki
April 16, 2021

Morin alleviates fructose-induced metabolic syndrome in rats via ameliorating oxidative stress, inflammatory and fibrotic markers.

The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology
Gehan Hussein HeebaMohamed Montaser Khalifa
April 16, 2021

Systemic immune-inflammation index is associated with increased carotid intima-media thickness in hypertensive patients.

Clinical and Experimental Hypertension : CHE
Ömer Faruk Çırakoğlu, Ahmet Seyda Yılmaz

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved
/feed-previews/biomarkers-for-cardiovascular-risk/6206ce3c-e7b0-48bb-8104-1ef3a959b60c